BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 118551)

  • 21. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model.
    Yamaguchi-Okada M; Nishizawa S; Mizutani A; Namba H
    Cerebrovasc Dis; 2009; 28(2):135-42. PubMed ID: 19506373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor.
    Yanamoto H; Kikuchi H; Okamoto S; Nozaki K
    Surg Neurol; 1994 Nov; 42(5):374-81. PubMed ID: 7974140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of cerebral vasospasm following subarachnoid hemorrhage in monkeys.
    Macdonald RL; Weir BK; Grace MG; Chen MH; Martin TP; Young JD
    Can J Neurol Sci; 1992 Nov; 19(4):419-27. PubMed ID: 1423039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys.
    Inoue T; Shimizu H; Kaminuma T; Tajima M; Watabe K; Yoshimoto T
    Neurosurgery; 1996 Nov; 39(5):984-90. PubMed ID: 8905755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasospasm and cerebral blood flow after subarachnoid hemorrhage.
    Ritchie WL; Overton TR
    J Can Assoc Radiol; 1980 Dec; 31(4):230-3. PubMed ID: 6778882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.
    Alksne JF; Greenhoot JH
    J Neurosurg; 1974 Oct; 41(4):440-5. PubMed ID: 4213103
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental model of symptomatic vasospasm in rabbits.
    Endo S; Branson PJ; Alksne JF
    Stroke; 1988 Nov; 19(11):1420-5. PubMed ID: 3188126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral vasospasm. Part I. In cerebral vascular malformations.
    Mohr JP; Kase CS
    Rev Neurol (Paris); 1983; 139(2):99-113. PubMed ID: 6410488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of inflammation in experimental cerebral vasospasm.
    Peterson JW; Kwun BD; Hackett JD; Zervas NT
    J Neurosurg; 1990 May; 72(5):767-74. PubMed ID: 2182792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm.
    Lewis PJ; Weir BK; Nosko MG; Tanabe T; Grace MG
    Neurosurgery; 1988 Mar; 22(3):492-500. PubMed ID: 3362315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
    Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
    J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential morphological changes of the constrictive basilar artery in a canine model of experimental cerebral vasospasm by talc injection.
    Mori T; Nagata K; Ishida T; Nikaido H; Kobayashi E; Sasaki T; Ohami H; Kirino T
    J Vet Med Sci; 1994 Jun; 56(3):535-40. PubMed ID: 7948385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Satoh M; Date I; Nakajima M; Takahashi K; Iseda K; Tamiya T; Ohmoto T; Ninomiya Y; Asari S
    Stroke; 2001 Jan; 32(1):225-31. PubMed ID: 11136941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.
    Peterson JW; Nishizawa S; Hackett JD; Bun T; Teramura A; Zervas NT
    Stroke; 1990 Jan; 21(1):133-7. PubMed ID: 2300980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of cerebral vasospasm.
    Alksne JF; Branson PJ
    Neurol Res; 1980; 2(3-4):273-82. PubMed ID: 6111035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
    Stoodley M; Weihl CC; Zhang ZD; Lin G; Johns LM; Kowalczuk A; Ghadge G; Roos RP; Macdonald RL
    Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical grade, regional cerebral blood flow, and angiographical spasm in the monkey after subarachnoid hemorrhage.
    Petruk KC
    Trans Am Neurol Assoc; 1973; 98():142-4. PubMed ID: 4206368
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of prazosin hydrochloride on cerebral vasospasm--an experimental study].
    Ishibashi Y; Konda R; Yoshimoto T; Suzuki J
    No Shinkei Geka; 1984 Feb; 12(2):133-9. PubMed ID: 6717739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.